Patients with personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should not use semaglutide
GHK-Cu Side Effects and Safety Potential concerns include: Skin irritation, redness, or sensitivity (with topical use) Variable absorption depending on formulation, but newer research has demonstrated that adding in a transport vessel such as liposomes can help with topical absorption (12)
In the ESSENCE trial involving participants with biopsy-confirmed MASH and stage 2 or 3 fibrosis, over half of whom had T2DM, interim analysis at 72 weeks showed 63% of those treated with semaglutide 2.4 mg weekly achieved resolution of steatohepatitis without worsening of fibrosis, compared with 34% in the placebo group
My father had his first heart attack at 58 and I could see myself heading down that same road
Ongoing phase 3 trials are in progress, and CagriSema is currently under FDA review, with a decision expected in late 2026
Chronic active Epstein-Barr virus (CAEBV) is a rare syndrome where the virus stays active, causing long-term illness
